Key market opportunities in the CNS Biomarkers sector include utilizing AI and technologies like ML and NLP to enhance drug ...

ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M ...

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...

Proteomics is emerging as a promising approach for identifying autism biomarkers by detecting protein-level changes linked to ...

In the past decade, immune checkpoint inhibitors (ICIs) have dramatically changed cancer treatment, significantly improving ...

Researchers found that loss of HDAC7 disrupted B-cell maturation in mouse models. Restoring HDAC7 suppressed tumor growth, ...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but can cause immune‑mediated hepatotoxicity (IMH), a potentially serious ...

Since President Donald J. Trump’s executive order to increase access to psychedelics and other alternative therapies for ...

The AI-driven platform delivers tumor treatment predictive biomarkers to oncology researchers faster, more accurately, and at scale.MILWAUKEE & NEWTON, Mass.--(BUSINESS WIRE)--#4DPath--Versiti ...

GEn1E Lifesciences Inc., a Phase 2 clinical-stage biotechnology company advancing AI-driven novel precision medicines for immunology, inflammation, and rare diseases, today announced a strategic ...

Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, disease progression in the ...